Beam Therapeutics Inc. (BEAM): Weighted Average Diluted Shares
98.91M
Year ended 2025-12-31
+12.2%
3-year compound annual growth
+16.2%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 98.91M | +20.2% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | 82.31M | +6.7% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | 77.15M | +10.2% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | 70.02M | +9.0% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | 64.23M | +37.4% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | 46.73M | +621.2% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | 6.48M | n/a | 2022-02-28, From 2019-01-01 |